Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

BIOMACROMOLECULES, published by the American Chemical Society, stands as a premier journal in the fields of bioengineering, biomaterials, materials chemistry, and polymers and plastics. With a commendable impact factor that places it in the Q1 category across these disciplines, it is recognized for its influential research contributions and is ranked strongly within its scopes—16th in Polymers and Plastics and 26th in Biomaterials according to Scopus. Since its inception in 2000 and continuing through 2024, the journal has been pivotal in disseminating significant findings and technological advancements that propel the field forward. Although it does not currently have an open access option, the journal offers invaluable insights that are essential for researchers, professionals, and students engaged in the cutting-edge exploration of macromolecules and their diverse applications. With its address located at 1155 16th St, NW, Washington, DC 20036, BIOMACROMOLECULES is not just a repository of knowledge but also a vital platform for fostering collaboration and innovation within the scientific community.

Bioinspired Biomimetic and Nanobiomaterials is a distinguished journal published by Emerald Group Publishing Ltd, focusing on the cutting-edge intersection of biomaterials, engineering, and nanotechnology. Since its inception in 2012, the journal has provided a vital platform for researchers, professionals, and students to disseminate innovative findings that draw inspiration from nature to develop novel biomimetic and bioinspired materials. Although currently indexed in the fourth quartile for Biomaterials and third quartile for miscellaneous Engineering in 2023, the journal is committed to improving its standing and impact by welcoming contributions that exploit the functional capabilities of nanoscale and biomimetic structures. With a strategic aim to foster interdisciplinary collaboration, this journal plays an instrumental role in advancing the field of biomaterials and engineering. Join our community and contribute to shaping the future of sustainable material design and applications.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

Advanced Healthcare Materials, published by WILEY, is a leading journal in the interdisciplinary fields of biomaterials, biomedical engineering, and pharmaceutical science. With its ISSN 2192-2640 and E-ISSN 2192-2659, the journal provides a platform for innovative research that encompasses the design, fabrication, and application of advanced materials in healthcare settings. Recognized for its high impact, it boasts a Q1 ranking in several categories, including a notable rank of #7/183 in Pharmaceutical Science and 14/137 in Biomaterials according to Scopus rankings. This reflects the journal’s commitment to publishing cutting-edge studies that push the boundaries of science and technology in medicine. Although it operates under a subscription model, articles published in this journal significantly impact the global research community and play a crucial role in the advancement of healthcare technologies. With a publication history from 2012 to 2024, Advanced Healthcare Materials remains an essential resource for researchers, professionals, and students engaged in the groundbreaking intersections of materials science and healthcare.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.

Biomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.

APL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.

Biointerphases is a distinguished academic journal published by AIP Publishing, showcasing cutting-edge research in the fields of biochemistry, biomaterials, chemistry, and materials science. With an ISSN of 1934-8630 and E-ISSN 1559-4106, this journal has made significant strides since its inception in 2008, continuing to provide a platform for innovative studies through 2024. As a testament to its relevance, it proudly holds Q2 and Q3 rankings across various categories, reflecting its critical role in advancing these multidisciplinary fields. Although not classified as an open-access journal, it maintains a respected position with a noteworthy impact factor and is highly valued by researchers, professionals, and students alike. Based in the United States at 1305 Walt Whitman Rd, Ste 300, Melville, NY 11747-4501, Biointerphases facilitates the exchange of ideas and findings that are vital to the progression of scientific knowledge and application.

Biomedical Physics & Engineering Express, published by IOP Publishing Ltd, serves as a dynamic platform for the dissemination of groundbreaking research in the interdisciplinary domains of biomedical physics, engineering, and related fields. With a focus on innovative solutions for healthcare challenges, the journal extends its reach to a global audience, providing valuable insights that influence both academic research and practical applications. Operating under an open-access format, this journal ensures that vital scientific discoveries are readily available to researchers, professionals, and students alike. Ranking within the Q3 and Q4 quartiles across various categories—including Bioengineering and Biomedical Engineering—indicates its emerging influence in the scientific community since its inception in 2015. With an increasing footprint in Scopus rankings and a commitment to advancing knowledge in subfields such as biophysics and health informatics, Biomedical Physics & Engineering Express plays a crucial role in shaping future innovations in healthcare technology and patient care.